片仔癀：温胆片Ⅲ期临床试验完成首例受试者入组

Core Viewpoint - The company has initiated the Phase III clinical trial for its innovative traditional Chinese medicine, Wen Dan Pian, which aims to treat mild to moderate generalized anxiety disorder [1] Group 1: Clinical Development - The first subject has been enrolled in the Phase III clinical trial for Wen Dan Pian, which is designed to evaluate its efficacy and safety in treating generalized anxiety disorder [1] - The trial is a multicenter, randomized, double-blind, placebo-controlled study [1] - Wen Dan Pian is known for its effects in regulating qi, resolving phlegm, and calming the mind, and has been used clinically since 2007 as a hospital preparation [1]